Faron Pharmaceuticals logo

Faron Pharmaceuticals

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. It focuses on the discovery and development of anti-scarring drugs, immunotherapy treatments, and cancer vaccines. The company’s product pipeline includes Traumakine, which is used in the treatment of acute respiratory distress syndrome; Clevegen that targets the programmed cell death 1/programmed cell death ligand 1 pathway involved in tumor growth and suppression; and preclinical stage product candidates, such as Apograft for the treatment of solid tumors. Faron Pharmaceuticals Oy was founded in 2000 and is headquartered in Turku, Finland.

Latest events on Quartr

Upcoming events for Faron Pharmaceuticals

Previous Events for Faron Pharmaceuticals





About the company


Investor Relations page


Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot